Home » Topics » Regulatory

Regulatory
RSS

Fablyn approved in Europe for the treatment of osteoporosis

March 26, 2009

FDA approves Symbyax for treatment-resistant depression

March 24, 2009

Dainippon launches Trerief in Japan for Parkinson's disease

March 16, 2009

FDA approves expanded indication for peginterferon-based combination therapy

March 13, 2009

Mepact receives E.U. approval for non-metastatic resectable osteosarcoma

March 11, 2009

Menarini launches CV Therapeutics' Ranexa in the U.K. and Germany

March 5, 2009

Sanofi pasteur's intradermal microinjection influenza vaccine approved in E.U.

Feb. 26, 2009

Valdoxan approved for the treatment of major depressive episodes in Europe

Feb. 26, 2009

European Commission approves Efient for acute coronary syndrome

Feb. 24, 2009

Priligy receives first regulatory approvals for premature ejaculation

Feb. 10, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...